Oragenics Inc
OGENNYSECIK 1174940HealthcareFiscal year ends Dec 31
Reports and events: 420 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-09-0516:45 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-035166 |
| 2024-09-0316:06 ET | S-1/A | Registration statement, amended | 0001493152-24-034815 |
| 2024-08-2108:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-033383 |
| 2024-08-1616:45 ET | S-1 | Registration statement | 0001493152-24-032843 |
| 2024-08-1616:30 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-032831 |
| 2024-08-1408:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-031898 |
| 2024-08-1208:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-031163 |
| 2024-08-0916:30 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-031000 |
| 2024-08-0808:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-030682 |
| 2024-07-2216:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-028687 |
| 2024-07-1008:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-026724 |
| 2024-06-2616:35 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-025281 |
| 2024-06-2008:00 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-24-024423 |
| 2024-05-2309:27 ET | 8-K | 5.08 Item not in the standard list | 0001493152-24-021103 |
| 2024-05-2208:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-020964 |
| 2024-05-1708:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-020362 |
| 2024-05-1608:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-020128 |
| 2024-05-1513:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-019655 |
| 2024-05-0708:14 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-018025 |
| 2024-04-2217:48 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-015404 |
| 2024-04-1620:01 ET | 8-K | 5.08 Item not in the standard list | 0001493152-24-014704 |
| 2024-03-2916:16 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-011979 |
| 2024-03-1807:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-010192 |
| 2024-03-0116:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-008489 |
| 2024-02-2809:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-008053 |
| 2024-02-2817:48 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-008022 |
| 2024-02-1220:06 ET | SC 13D | Ownership report, active investor | 0001683168-24-000887 |
| 2024-02-1216:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-005916 |
| 2024-02-0708:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-005201 |
| 2024-02-0508:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-004887 |
| 2024-01-2317:18 ET | 8-K | 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-003487 |
| 2024-01-1609:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-002364 |
| 2024-01-0209:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-000041 |
| 2023-12-2907:30 ET | 8-K | 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-046468 |
| 2023-12-1515:45 ET | 8-K | 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-23-045030 |
| 2023-12-0816:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-23-044220 |
| 2023-11-2015:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-042073 |
| 2023-11-0916:15 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-23-040060 |
| 2023-11-0207:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-039075 |
| 2023-10-3016:00 ET | DEF 14A | Proxy statementPeriod 2023-10-30 | 0001493152-23-038666 |
| 2023-10-0517:29 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-036400 |
| 2023-10-0506:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-035743 |
| 2023-09-2916:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-034826 |
| 2023-09-1516:00 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-032757 |
| 2023-08-1816:15 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-23-029443 |
| 2023-08-1116:16 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001493152-23-027838 |
| 2023-08-1016:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-027575 |
| 2023-08-0708:09 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-026968 |
| 2023-06-0516:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-020120 |
| 2023-05-1216:51 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001493152-23-016708 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:40 ET. Listed shows no prices and gives no investment advice.